1 July 2022 - The NHS has saved taxpayers £1.2 billion in just three years, while securing cutting-edge treatments for patients, by using its buying power to negotiate better prices for hundreds of hospital medicines.
The adoption of cheaper versions of a single drug – adalimumab – which is used to treat more than 45,000 patients with rheumatoid arthritis, inflammatory bowel disease and psoriasis, has accounted for about one third of the savings.